Mineralys Therapeutics, Inc.(MLYS)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MLYS Mineralys Therapeutics, Inc.

未开盘 10-15 16:00:00 EDT

13.70

+0.11

+0.81%

盘后13.70

+0.000.00%

16:02 EDT

最高13.87	最低13.42	成交量6.51万
今开13.53	昨收13.59	日振幅3.34%
总市值6.81亿	流通市值3.26亿	总股本4,973万
成交额89.21万	换手率0.27%	流通股本2,382万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MLYS","market":"US","secType":"STK","nameCN":"Mineralys Therapeutics, Inc.","latestPrice":13.7,"timestamp":1729022400000,"preClose":13.59,"halted":0,"volume":65103,"hourTrading":{"tag":"盘后","latestPrice":13.7,"preClose":13.7,"latestTime":"16:02 EDT","volume":2721,"amount":37277.7,"timestamp":1729022521584},"delay":0,"floatShares":23820608,"shares":49726675,"eps":-2.743059,"marketStatus":"未开盘","marketStatusCode":0,"change":0.11,"latestTime":"10-15 16:00:00 EDT","open":13.53,"high":13.874,"low":13.42,"amount":892118.583261,"amplitude":0.033407,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.743059,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1729065600000},"adr":0,"listingDate":1676005200000,"adjPreClose":13.59,"postHourTrading":{"tag":"盘后","latestPrice":13.7,"preClose":13.7,"latestTime":"16:02 EDT","volume":2721,"amount":37277.7,"timestamp":1729022521584},"volumeRatio":0.42722,"impliedVol":1.7197,"impliedVolPercentile":0.9643},"requestUrl":"/m/hq/s/MLYS","defaultTab":"news","newsList":[{"id":"2473999578","title":"Mineralys Therapeutics, Inc.盘中异动 下午盘股价大涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473999578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473999578?lang=zh_cn&edition=full","pubTime":"2024-10-05 02:56","pubTimestamp":1728068211,"startTime":"0","endTime":"0","summary":"北京时间2024年10月05日02时56分，Mineralys Therapeutics, Inc.股票出现波动，股价快速上涨5.42%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Entero Therapeutics Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Aditxt, Inc.、Seelos Therapeutics, Inc.、Theriva Biologics, Inc.较为活跃，换手率分别为17546.89%、94.36%、78.40%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Aditxt, Inc.、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为103.24%、69.59%、58.64%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410050256519719e6fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410050256519719e6fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MLYS","LENZ"],"gpt_icon":0},{"id":"2468501365","title":"Mineralys Therapeutics, Inc.盘中异动 快速拉升5.13%报12.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468501365","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468501365?lang=zh_cn&edition=full","pubTime":"2024-09-19 23:29","pubTimestamp":1726759799,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日23时29分，Mineralys Therapeutics, Inc.股票出现异动，股价急速上涨5.13%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.76%。其相关个股中，Exicure, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Edgewise Therapeutics, Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Portage Biotech Inc.较为活跃，换手率分别为4229.50%、796.71%、183.49%，振幅较大的相关个股有Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为99.34%、78.69%、52.97%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919232959a1db3637&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919232959a1db3637&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MLYS","BK4139","LENZ"],"gpt_icon":0},{"id":"2460063440","title":"Mineralys Therapeutics, Inc.盘中异动 下午盘快速上涨5.50%报10.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460063440","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460063440?lang=zh_cn&edition=full","pubTime":"2024-08-20 02:43","pubTimestamp":1724093036,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日02时43分，Mineralys Therapeutics, Inc.股票出现异动，股价大幅上涨5.50%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.12%。其相关个股中，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为8948.14%、3773.76%、1276.42%，振幅较大的相关个股有Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为405.90%、220.18%、198.02%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082002435697199309&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082002435697199309&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MLYS","BK4139"],"gpt_icon":0},{"id":"2460710100","title":"Mineralys Therapeutics, Inc.2024财年第二财季实现净利润-41.01百万美元，同比减少237.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460710100","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460710100?lang=zh_cn&edition=full","pubTime":"2024-08-19 00:05","pubTimestamp":1723997101,"startTime":"0","endTime":"0","summary":"8月19日，Mineralys Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-41.01百万美元，同比减少237.81%；其中营业收入为0.00美元，每股基本收益为-0.83美元。机构评级：截至2024年8月19日，当前有7家机构对Mineralys Therapeutics, Inc.目标价做出预测，其中目标均价为33.00美元，其中最低目标价为26.00美元，最高目标价为45.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081900051195a38704&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081900051195a38704&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MLYS"],"gpt_icon":0},{"id":"2459724531","title":"Mineralys Therapeutics, Inc.盘中异动 快速跳水7.61%报10.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459724531","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459724531?lang=zh_cn&edition=full","pubTime":"2024-08-14 21:31","pubTimestamp":1723642286,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日21时31分，Mineralys Therapeutics, Inc.股票出现波动，股价急速下跌7.61%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Conduit Pharmaceuticals Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Genprex, Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Viracta Therapeutics, Inc.、Genprex, Inc.较为活跃，换手率分别为49.00%、42.74%、22.97%，振幅较大的相关个股有Genprex, Inc.、Acelyrin, Inc.、Cadrenal Therapeutics, Inc.，振幅分别为12.91%、9.24%、8.88%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408142131269f2ac0cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408142131269f2ac0cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MLYS","LENZ"],"gpt_icon":0},{"id":"2459953942","title":"Mineralys Therapeutics, Inc.盘中异动 急速上涨5.04%报11.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459953942","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459953942?lang=zh_cn&edition=full","pubTime":"2024-08-13 03:19","pubTimestamp":1723490368,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日03时19分，Mineralys Therapeutics, Inc.股票出现异动，股价大幅上涨5.04%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.50%。其相关个股中，Revance Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Cingulate Inc.涨幅较大，60 Degrees Pharmaceuticals, Inc.、Entero Therapeutics Inc.、Oragenics Inc.较为活跃，换手率分别为696.24%、659.33%、99.21%，振幅较大的相关个股有Entero Therapeutics Inc.、60 Degrees Pharmaceuticals, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 ，振幅分别为117.04%、91.10%、53.94%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081303192894200108&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081303192894200108&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MLYS","BK4139","LENZ"],"gpt_icon":0},{"id":"2458544614","title":"Mineralys Therapeutics Inc    预计每股亏损 70 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2458544614","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458544614?lang=zh_cn&edition=full","pubTime":"2024-08-10 05:07","pubTimestamp":1723237642,"startTime":"0","endTime":"0","summary":"   * Mineralys Therapeutics Inc    将于8月13日公布截至2024年6月30日的财报，预计该公司的季度收入将保持不变。*    * LSEG分析师对Mineralys Therapeutics Inc的平均预期是每股亏损70美分。* 华尔街对 Mineralys Therapeutics Inc 的 12 个月目标价中位数为 32.00 美元，高于其最新收盘价 11.17 美元。8月9日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","LENZ"],"gpt_icon":0},{"id":"2457102778","title":"Mineralys Therapeutics, Inc.盘中异动 早盘股价大跌6.51%报11.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457102778","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457102778?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:38","pubTimestamp":1722865092,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时38分，Mineralys Therapeutics, Inc.股票出现异动，股价大幅下跌6.51%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.94%。其相关个股中，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Zevra Therapeutics, Inc.、Oculis Holding Ag C/Wts 06/03/2028 涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为1068.25%、51.48%、14.09%，振幅较大的相关个股有Alterity Therapeutics Limited、Cns Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.，振幅分别为20.00%、19.99%、17.59%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052138129f107304&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052138129f107304&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MLYS","LENZ","BK4139"],"gpt_icon":0},{"id":"2452719103","title":"Mineralys Therapeutics, Inc.盘中异动 临近收盘快速下挫5.01%报13.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452719103","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452719103?lang=zh_cn&edition=full","pubTime":"2024-07-18 03:56","pubTimestamp":1721246180,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日03时56分，Mineralys Therapeutics, Inc.股票出现异动，股价大幅下跌5.01%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.17%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Aptevo Therapeutics Inc.、Moolec Science Sa C/Wts 涨幅较大，Aptevo Therapeutics Inc.、Aditxt, Inc.、Longeveron Inc.较为活跃，换手率分别为4045.02%、1505.85%、334.14%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Geovax Labs Inc C/Wts 29/09/2025、Cyclerion Therapeutics, Inc.，振幅分别为76.39%、52.63%、48.13%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407180356209681dbcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407180356209681dbcc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MLYS","BK4139","LENZ"],"gpt_icon":0},{"id":"2450996143","title":"Mineralys Therapeutics, Inc.盘中异动 下午盘股价大涨5.00%报13.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450996143","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450996143?lang=zh_cn&edition=full","pubTime":"2024-07-12 01:45","pubTimestamp":1720719936,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日01时45分，Mineralys Therapeutics, Inc.股票出现波动，股价急速上涨5.00%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Neximmune, Inc.、Biodexa Pharmaceuticals Plc、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Neximmune, Inc.、Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited较为活跃，换手率分别为1769.45%、657.98%、656.57%，振幅较大的相关个股有Neximmune, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Kazia Therapeutics Limited，振幅分别为205.40%、149.14%、99.82%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712014536af91e391&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712014536af91e391&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MLYS","BK4139","LENZ"],"gpt_icon":0},{"id":"2448942533","title":"Mineralys Therapeutics, Inc.盘中异动 股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448942533","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448942533?lang=zh_cn&edition=full","pubTime":"2024-07-02 03:52","pubTimestamp":1719863533,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日03时52分，Mineralys Therapeutics, Inc.股票出现异动，股价大幅拉升5.13%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Senti Biosciences, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 涨幅较大，Senti Biosciences, Inc.、Geovax Labs, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为839.90%、210.77%、134.83%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Senti Biosciences, Inc.、Cingulate Inc.，振幅分别为168.39%、101.49%、82.81%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702035213af900c1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702035213af900c1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MLYS"],"gpt_icon":0},{"id":"2446390670","title":"Mineralys Therapeutics, Inc.盘中异动 大幅下挫5.01%报11.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446390670","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446390670?lang=zh_cn&edition=full","pubTime":"2024-06-26 23:08","pubTimestamp":1719414539,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日23时08分，Mineralys Therapeutics, Inc.股票出现异动，股价大幅下挫5.01%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.87%。其相关个股中，Anew Medical, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Diamedica Therapeutics Inc.涨幅较大，Anew Medical, Inc.、Cns Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃，换手率分别为582.05%、125.28%、94.91%，振幅较大的相关个股有Anew Medical, Inc.、Effector Therapeutics Inc C/Wts 31/12/2025 、Moolec Science Sa C/Wts ，振幅分别为107.88%、51.85%、39.62%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626230859aef6c196&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626230859aef6c196&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MLYS","LENZ"],"gpt_icon":0},{"id":"2437508577","title":"Mineralys Therapeutics, Inc.盘中异动 急速下跌5.75%报11.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437508577","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437508577?lang=zh_cn&edition=full","pubTime":"2024-05-23 21:34","pubTimestamp":1716471283,"startTime":"0","endTime":"0","summary":"北京时间2024年05月23日21时34分，Mineralys Therapeutics, Inc.股票出现异动，股价急速跳水5.75%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Geovax Labs Inc C/Wts 29/09/2025、Altamira Therapeutics Ltd.涨幅较大，Altamira Therapeutics Ltd.、Theriva Biologics, Inc.、Mustang Bio, Inc.较为活跃，换手率分别为401.30%、80.91%、32.45%，振幅较大的相关个股有Altamira Therapeutics Ltd.、Alpha Tau Medical Ltd C/Wts 、Geovax Labs, Inc.，振幅分别为19.58%、17.96%、14.44%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523213443941e9a8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240523213443941e9a8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MLYS","LENZ","BK4139"],"gpt_icon":0},{"id":"2436811321","title":"Mineralys Therapeutics, Inc.2024财年第一财季实现净利润-31.51百万美元，同比减少149.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436811321","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2436811321?lang=zh_cn&edition=full","pubTime":"2024-05-19 00:17","pubTimestamp":1716049035,"startTime":"0","endTime":"0","summary":"3月31日，Mineralys Therapeutics, Inc.公布财报，公告显示公司2024财年第一财季净利润为-31.51百万美元，同比减少149.88%；其中营业收入为0.00美元，每股基本收益为-0.70美元。机构评级：截至2024年3月31日，当前有6家机构对Mineralys Therapeutics, Inc.目标价做出预测，其中目标均价为33.50美元，其中最低目标价为26.00美元，最高目标价为45.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405190017288b15ec41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405190017288b15ec41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MLYS","LENZ"],"gpt_icon":0},{"id":"2435165301","title":"Mineralys Therapeutics, Inc.盘中异动 快速下跌5.03%报12.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435165301","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435165301?lang=zh_cn&edition=full","pubTime":"2024-05-14 03:10","pubTimestamp":1715627413,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日03时10分，Mineralys Therapeutics, Inc.股票出现波动，股价大幅下挫5.03%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.34%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405140310137a599fcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405140310137a599fcd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MLYS","LENZ","BK4139"],"gpt_icon":0},{"id":"2434480140","title":"Mineralys Therapeutics, Inc.盘中异动 股价大跌6.08%报13.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434480140","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434480140?lang=zh_cn&edition=full","pubTime":"2024-05-10 00:54","pubTimestamp":1715273660,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日00时54分，Mineralys Therapeutics, Inc.股票出现异动，股价快速下跌6.08%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Seres Therapeutics, Inc.、Notable Labs, Ltd.涨幅较大，Notable Labs, Ltd.、Allarity Therapeutics, Inc.、G1 Therapeutics, Inc.较为活跃，换手率分别为163.15%、160.68%、55.60%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Notable Labs, Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为58.46%、57.24%、51.01%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510005420861ec276&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510005420861ec276&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MLYS","BK4139"],"gpt_icon":0},{"id":"2433783534","title":"Mineralys Therapeutics Inc   预计每股亏损67美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433783534","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433783534?lang=zh_cn&edition=full","pubTime":"2024-05-07 21:57","pubTimestamp":1715090264,"startTime":"0","endTime":"0","summary":"   * Mineralys Therapeutics Inc    将于5月9日公布截至2024年3月31日的财报，预计该公司的季度收入将保持不变。*    * LSEG分析师对Mineralys Therapeutics Inc的平均预期是每股亏损67美分。* 华尔街对 Mineralys Therapeutics Inc 的 12 个月目标价中位数为 32.50 美元，高于其最后收盘价 13.75 美元。5月7日 - 以前季度业绩。除非另有说明，所有数字均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","MLYS"],"gpt_icon":0},{"id":"2433228806","title":"Mineralys Therapeutics, Inc.盘中异动 快速拉升5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433228806","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433228806?lang=zh_cn&edition=full","pubTime":"2024-05-07 01:41","pubTimestamp":1715017267,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日01时41分，Mineralys Therapeutics, Inc.股票出现异动，股价急速拉升5.17%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nrx Pharmaceuticals, Inc.、Nanoviricides, Inc.涨幅较大，Tc Biopharm  Plc、Allarity Therapeutics, Inc.、Lyra Therapeutics, Inc.较为活跃，换手率分别为1233.59%、792.29%、155.39%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Tc Biopharm  Plc、Nrx Pharmaceuticals, Inc.，振幅分别为95.51%、92.47%、68.10%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050701410787e85e05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050701410787e85e05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MLYS","BK4139"],"gpt_icon":0},{"id":"2432835816","title":"Mineralys Therapeutics, Inc.盘中异动 快速上涨5.06%报12.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432835816","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432835816?lang=zh_cn&edition=full","pubTime":"2024-05-02 00:09","pubTimestamp":1714579771,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日00时09分，Mineralys Therapeutics, Inc.股票出现波动，股价快速上涨5.06%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Cytomx Therapeutics, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Psyence Biomedical Ltd.涨幅较大，Palisade Bio, Inc.、Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1321.64%、210.45%、50.45%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为188.34%、77.43%、66.20%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502000932861ea8dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502000932861ea8dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MLYS","LENZ","BK4139"],"gpt_icon":0},{"id":"2429112818","title":"Mineralys Therapeutics, Inc.盘中异动 临近午盘股价大涨5.30%报11.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429112818","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2429112818?lang=zh_cn&edition=full","pubTime":"2024-04-23 23:58","pubTimestamp":1713887887,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日23时58分，Mineralys Therapeutics, Inc.股票出现波动，股价快速拉升5.30%。Mineralys Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.40%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Abvc Biopharma, Inc.涨幅较大，Palisade Bio, Inc.、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为2500.31%、177.90%、42.97%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Psyence Biomedical Ltd C/Wts 25/01/2029、Palisade Bio, Inc.，振幅分别为80.08%、56.09%、45.43%。Mineralys Therapeutics, Inc.公司简介：Mineralys Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发药物以治疗醛固酮异常升高引起的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042323580887e82e15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042323580887e82e15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MLYS","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mineralystx.com","stockEarnings":[{"period":"1week","weight":-0.0051},{"period":"1month","weight":0.1556},{"period":"3month","weight":-0.0679},{"period":"6month","weight":0.1325},{"period":"1year","weight":0.5},{"period":"ytd","weight":0.5802}],"compareEarnings":[{"period":"1week","weight":0.0291},{"period":"1month","weight":0.0397},{"period":"3month","weight":0.0345},{"period":"6month","weight":0.1674},{"period":"1year","weight":0.3542},{"period":"ytd","weight":0.2293}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Mineralys Therapeutics, Inc.最初成立于2019年5月31日，是特拉华州的一家公司。该公司是一家临床阶段生物制药公司，专注于开发药物，以治疗由异常升高的醛固酮引起的疾病。该公司的候选产品氯隆前列素是一种专有的口服高选择性醛固酮合酶抑制剂（ASI），该公司最初开发用于治疗未控制的高血压（uHTN）患者，定义为尽管服用了两种或多种抗高血压药物或抵抗性高血压（rHTN），但血压仍不能达到130/80mmHg以下的个体。在美国，有超过1.15亿患者患有持续性高血压（BP）或高血压，超过一半的患者未能实现血压目标，即目前可用的药物血压为130/80 mmHg。超过3000万接受治疗的患者没有达到血压目标，其中约2000万患者的收缩压水平超过140 mmHg。尽管服用了两种或两种以上药物，但高血压患者仍持续存在，心血管疾病或中风导致的死亡率风险分别为1.8倍和2.5倍。在一项评估200名uHTN和rHTN（目标HTN）受试者的第2阶段临床试验中，洛龙前列素显示，每天给药一次，血压下降具有临床意义和统计学意义，且耐受性良好。除高血压外，该公司还打算开发用于治疗慢性肾脏病（CKD）的氯前列素。","exchange":"NASDAQ","name":"Mineralys Therapeutics, Inc.","nameEN":"Mineralys Therapeutics, Inc."},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.0","shortVersion":"4.29.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mineralys Therapeutics, Inc.(MLYS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Mineralys Therapeutics, Inc.(MLYS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Mineralys Therapeutics, Inc.,MLYS,Mineralys Therapeutics, Inc.股票,Mineralys Therapeutics, Inc.股票老虎,Mineralys Therapeutics, Inc.股票老虎国际,Mineralys Therapeutics, Inc.行情,Mineralys Therapeutics, Inc.股票行情,Mineralys Therapeutics, Inc.股价,Mineralys Therapeutics, Inc.股市,Mineralys Therapeutics, Inc.股票价格,Mineralys Therapeutics, Inc.股票交易,Mineralys Therapeutics, Inc.股票购买,Mineralys Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mineralys Therapeutics, Inc.(MLYS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Mineralys Therapeutics, Inc.(MLYS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况